Status
Conditions
Treatments
About
The objective of this retrospective study is to describe in real-life settings the clinical practice, utilization and the treated population outcomes at 1-year (12-16 months) follow-up at selected, representative centers in France.
Full description
This proposed ATLAS FR study will be a retrospective review conducted to expand our knowledge of the clinical outcomes in subjects treated in France between 01 February 2017 and 01 March 2018.
This will provide a comprehensive data set that is specifically representative of the Atlas stent use in France.
Enrollment
Sex
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
Loading...
Central trial contact
Caroline Le Page, RN
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal